Researchers developed MassiveFold, an enhanced AlphaFold version optimized for parallel processing, which accelerates protein ...

Google DeepMind releases AlphaFold 3's source code to academics, marking a significant advance in AI-powered molecular biology and drug discovery, while balancing open science with commercial ...

AK132 is an asymmetric bispecific antibody ... tumor antigen target in gastric and pancreatic cancers. Studies have demonstrated that AK132 binds with high affinity to both human CLDN18.2 and human ...

Good afternoon and welcome to today's conference call for Omeros Corporation. (Operator Instructions) Please be advised that this call is being recorded at the company's request and a replay will be ...

Pediatric RSV off-season outbreaks and positivity rates increased in China during the COVID-19 pandemic, according to study findings.

Over the last several quarters, we have had a series of interactions with the agency focused on our ... In addition to our complement antibodies, narsoplimab, zaltenibart and OMS1029, we continue ...

MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritis Two trials for active psoriatic arthritis (PsA) with one focusing on ...

Over the last 2 decades, significant progress has been made in our understanding of the genomics, tumor immune microenvironment, and immunogenicity of malignant melanoma. Historically, the prognosis ...

This handbook contains a comprehensive collection of protocols to streamline imaging workflows and ensure reproducible ...